financetom
Business
financetom
/
Business
/
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Biomarin Pharmaceutical Insider Sold Shares Worth $2,173,341, According to a Recent SEC Filing
Apr 1, 2024 2:06 PM

04:56 PM EDT, 04/01/2024 (MT Newswires) -- George Eric Davis, Executive Vice President, Chief Legal Officer, on March 28, 2024, sold 24,602 shares in Biomarin Pharmaceutical ( BMRN ) for $2,173,341. Following the Form 4 filing with the SEC, Davis has control over a total of 55,856 shares of the company, with 55,856 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1048477/000104847724000054/xslF345X03/wk-form4_1712004839.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved